Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
2.495
-0.065 (-2.54%)
May 14, 2025, 12:53 PM - Market open
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Biocatalysts, Pharmaceutical Intermediates, and Codex Biocatalyst Panels and Kits | 42.91M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Research and Development | 27.24M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Performance Enzymes | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Performance Enzymes Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Novel Biotherapeutics | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Novel Biotherapeutics Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| China | 20.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 13.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APAC | 13.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APAC Growth | -79.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA | 11.31M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA Growth | -80.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Switzerland | 11.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ireland | 500.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas | 33.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas Growth | -99.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|